Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?

Swiss Med Wkly. 2020 Apr 16:150:w20249. doi: 10.4414/smw.2020.20249. eCollection 2020 Apr 6.

Author

Francesco Negro¹

Affiliation

¹ Divisions of Gastroenterology and Hepatology and of Clinical Pathology, University Hospitals, Geneva, Switzerland.

PMID: 32298458
DOI: 10.4414/smw.2020.20249

No abstract available

MeSH terms

Antibody Formation*
Antibody-Dependent Enhancement*
Betacoronavirus / immunology
Betacoronavirus / pathogenicity*
COVID-19
COVID-19 Vaccines
China
Coronavirus / pathogenicity
Coronavirus Infections / immunology*
Coronavirus Infections / prevention & control
Dengue Virus / pathogenicity
Humans
Immunization, Passive
Pandemics
Pneumonia, Viral / immunology*
Receptors, Complement / metabolism
SARS-CoV-2
Severe acute respiratory syndrome-related coronavirus / pathogenicity
Severity of Illness Index
Vaccination
Viral Vaccines / immunology

Substances

COVID-19 Vaccines
Receptors, Complement
Viral Vaccines